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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
08.07.2020 COVID-19 
Mortality 
Risk 
Assessment: 
An 
International 
Multi-Center 
Study 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 This study seeks to 
develop and validate a 
data-driven personalized 
mortality risk calculator for 
hospitalized COVID-19 
patients. 
 This CMR model leverages 
machine learning to 
generate accurate mortality 
predictions using 
commonly available clinical 
features. This is the first 
risk score trained and 
validated on a cohort of 
COVID-19 patients from 
Europe and the United 
States. 
mortality 
  
2 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Articl
e type 
Summary Keywords 
08.07.2020 Diagnostics and 
spread of 
SARS-CoV-2 in 
Western Africa: 
An observational 
laboratory-
based study 
from Benin 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Information on 
SARS-CoV-2 
spread in Africa is 
limited by fragile 
surveillance 
systems and 
insufficient 
diagnostic 
capacity. 
 Study found a 15-
fold increase in the 
monthly laboratory 
workload due to 
COVID-19. 
Genomic 
surveillance 
showed 9 
introductions of 
three distinct 
SARS-CoV-2 
lineages. SARS-
CoV-2 genome-
based analyses 
yielded an R0 
estimate of 10 4.4 
(95% confidence 
interval: 2.0-7.7), 
suggesting intense 
spread of SARS-
CoV-2 in Africa. 
Growth rate 
08.07.2020 The COVID-19 
mortality effects 
of underlying 
health 
conditions in 
India: a 
modelling study 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Known COVID-19 
health risk factors 
are not expected 
to have a large 
effect on 
aggregate 
mortality or its age 
distribution in India 
relative to 
England. The high 
share of COVID-
19 deaths from 
people under 60 in 
low- and middle-
income countries 
(LMICs) remains 
unexplained. 
Understanding 
mortality risk 
Mortality, 
modelling 
3 
associated with 
health conditions 
prevalent in 
LMICs, such as 
malnutrition and 
HIV/AIDS, is 
essential for 
understanding 
differential 
mortality. 
08.07.2020 Reconstructing 
the global 
dynamics of 
under-
ascertained 
COVID-19 
cases and 
infections 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Study found 
substantial under-
ascertainment of 
symptomatic 
cases, particularly 
at the peak of the 
first wave of the 
SARS-CoV-2 
pandemic, in many 
countries. 
Reported case 
counts will 
therefore likely 
underestimate the 
rate of outbreak 
growth initially and 
underestimate the 
decline in the later 
stages of an 
epidemic.  
 Although there 
was considerable 
under-reporting in 
many 
locations,  estimat
es were consistent 
with emerging 
serological data, 
suggesting that the 
proportion of each 
country's 
population infected 
with SARS-CoV-2 
worldwide is 
generally low. 
Data 
06.07.2020 Prediction of 
COVID-19 
spreading 
profiles in South 
Korea, Italy and 
Iran by data-
driven coding 
PLOS One 
 This work applies 
a data-driven 
coding method for 
prediction of the 
COVID-19 
spreading profile in 
any given 
population that 
shows an initial 
Data 
4 
phase of epidemic 
progression. 
 Application of the 
method to the data 
collected for South 
Korea, Italy and 
Iran shows that 
peaks of infection 
cases are 
expected to occur 
before mid April, 
the end of March 
and the end of 
May 2020, and 
that the 
percentage of 
population infected 
in each city or 
region will be less 
than 0.01%, 0.5% 
and 0.5%, for 
South Korea, Italy 
and Iran, 
respectively. 
  
06.07.2020 Prevalence of 
SARS-CoV-2 in 
Spain (ENE-
COVID): a 
nationwide, 
population-
based 
seroepidemiolog
ical study 
The Lancet | 
Article 
 This article is 
included as is the 
first nationwide 
(Spain) population-
based study of 
seroprevalence 
estimates of 
antibodies against 
SARS-CoV-2 at 
national and 
regional levels 
 Only approx. 5% 
had C19 
antibodies with no 
differences by sex 
and lower 
seroprevalence in 
children younger 
than 10 years 
 There was 
substantial 
geographical 
variability, with 
higher prevalence 
around Madrid 
(>10%) and lower 
in coastal areas 
(<3%) 
Seroprevalenc
e  
5 
 95% of people in 
Spain are still 
susceptible, 
despite one of 
Europe’s most 
intense outbreaks 
 Herd immunity 
through natural 
infection is difficult 
to achieve and 
unethical, given 
the collateral 
damage of many 
deaths in the 
susceptible 
population and 
overburdening of 
health systems 
04.07.2020 The projected 
impact of 
mitigation and 
suppression 
strategies on the 
COVID-19 
epidemic in 
Senegal: A 
modelling study 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Senegal acted 
promptly to contain 
the spread of 
SARS-CoV-2 and 
has already 
significantly 
reduced 
transmission from 
1.9 (95% CI 1.7-
2.2) to 1.3 (95% CI 
1.2-1.5) but has 
not full interrupted 
transmission 
 This study 
estimates that 
continued spread 
is likely to peak in 
October, and to 
overwhelm the 
healthcare system 
with an estimated 
77,400 deaths 
(95% CI 55,270-
100,700) 
 Enhanced physical 
distancing 
measures could 
reduce the burden 
on healthcare 
services 
 Rapid scale up of 
hospital capacity is 
likely to be needed 
Mitigation, 
public health, 
healthcare 
capacity 
02.07.2020 Tracking 
changes in 
Cell | Article 
 A SARS-CoV-2 
variant with a 
change in an 
SARS-CoV-2 
variant 
6 
SARS-CoV-2 
Spike: evidence 
that D614G 
increases 
infectivity of the 
COVID-19 virus 
amino acid in the 
Spike protein has 
become the most 
prevalent form in 
the global 
pandemic with an 
increase at 
national, regional 
and municipal 
levels and even in 
local epidemics 
where the original 
form was well 
established 
 This pattern was 
highly statistically 
significant, 
suggesting that the 
new variant may 
have a fitness 
advantage with 
possible higher 
upper respiratory 
tract viral loads, 
but not increased 
disease severity 
 Important for a 
mechanistic 
understanding of 
the virus, and 
support of 
continuing 
surveillance of 
Spike mutations to 
aid in the 
development of 
immunological 
interventions 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
06.07.2020 Global 
resource 
shortages 
during 
COVID-
19: Bad 
news for 
PLOS 
Neglected 
Tropical 
Diseases 
 To better elucidate COVID 
preparedness in low-income 
countries, we combined data 
from all service provision 
assessments (SPAs) 
conducted in nationally 
representative surveys of 
hospitals within the past 5 
years in low-income 
PPE 
  
7 
low-
income 
countries 
countries, which included 
Afghanistan, Democratic 
Republic of the Congo 
(DRC), Haiti, Nepal, and 
Tanzania. 
 Conclusions: Continued local 
as well as international 
action is needed to ensure 
access to PPE for all health 
workers and respiratory 
support for all patients, not 
just for those living in 
resource-abundant 
countries. As COVID-19 
therapeutics and vaccines 
emerge, additional 
international commitment will 
be necessary to ensure 
global access. 
06.07.2020 Mobility 
restrictions 
for the 
control of 
epidemics: 
When do 
they work? 
PLOS One 
 Mobility restrictions may not 
be an effective policy for 
controlling the spread of an 
infectious disease if it is 
assessed by the overall final 
epidemic size. Patterns of 
mobility established through 
the independent mobility and 
trade decisions of people in 
both communities may be 
sufficient to contain 
epidemics. 
Mobility 
restrictions 
  
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
06.07.2020 An 
evaluation 
of COVID-
19 
serological 
assays 
informs 
future 
diagnostics 
and 
exposure 
assessment 
 Nature 
Communications 
| Article 
 A detailed comparison of 
serological COVID-19 
assays shows a wide 
diversity in assay 
performance in different 
scenarios and when 
correlated to virus 
neutralising antibodies 
  Serological 
assays 
8 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
06.07.2020 The Role of 
Remdesivir 
in South 
Africa: 
Preventing 
COVID-19 
Deaths 
Through 
Increasing 
ICU Capacity 
Clinical 
Infectious 
Diseases 
 Countries such as South 
Africa have limited 
intensive care unit (ICU) 
capacity to handle the 
expected number of 
COVID-19 patients 
requiring ICU care. 
Remdesivir can prevent 
deaths in countries such as 
South Africa by decreasing 
the number of days people 
spend in ICU, therefore 
freeing up ICU bed 
capacity. 
 Remdesivir 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
18.06.2020 Pausing 
the Fight 
Against 
Malaria to 
Combat the 
COVID-19 
Pandemic 
in Africa: Is 
the Future 
of Malaria 
Bleak? 
Frontiers in 
microbiology 
 Access to healthcare has 
generally been limited by 
COVID-19, while malaria 
interventions, such as 
seasonal malaria 
chemotherapy and 
distribution of insecticide-
treated bed nets, have been 
suspended due to 
lockdowns.  
 Likewise, the repurposing of 
antimalarials for treatment of 
COVID-19 shared symptoms 
and the shift in focus from 
the production of malaria 
rapid diagnostic tests 
(RDTs) to COVID-19 RDTs 
is a cause for concern in 
malaria-endemic regions.  
 Children are less affected by 
the COVID-19 pandemic 
compared to the elderly. 
However, due to the fears of 
contracting SARS-CoV-2, 
the elderly who are worst 
affected by COVID-19 may 
not take children for malaria 
Malaria 
9 
medication, resulting in high 
malaria-related mortalities 
among children.  
02.07.2020 The Impact 
of COVID-
19 on 
People 
With 
Diabetes in 
Brazil 
Diabetes 
research and 
clinical 
practise 
 Convenience sampling study 
with data collected from 
1701 individuals. 
 Study provides a firsthand 
revelation of the severity of 
COVID-19 on individuals 
with diabetes in Brazil, 
altering their habits, which 
impacted their glycemia, 
potentially increasing their 
risk of poor outcomes if 
infected by SARS-CoV-2. 
Diabetes 
Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
08.07.2020 Ranking the 
effectiveness 
of worldwide 
COVID-19 
government 
interventions 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Assessing the 
effectiveness of the 
individual 
interventions is critical 
to inform future 
preparedness 
response plans. 
 Emerging picture is 
one in which no one-
fits-all solution exists, 
and no single NPI 
alone can decrease Rt 
below one and that a 
combination of NPIs is 
necessary to curb the 
spread of the virus. 
 We show that there 
are NPIs considerably 
less intrusive and 
costly than lockdowns 
that are also highly 
effective, such as 
certain risk 
communication 
strategies and 
voluntary measures 
that strengthen the 
healthcare system. 
NPIs, 
government 
 01.07.2020  Effectiveness 
of government 
 SSRN 
 Assessment of the 
quantitative impact of 
government 
 Government, 
impact 
10 
policies in 
response to 
the COVID-19 
outbreak 
interventions on 
deaths related to the 
C19 outbreak 
 The greater the 
strength of 
government 
interventions at an 
early stage, the more 
effective these are in 
slowing down or 
reversing the growth 
rate of deaths 
 Informative for future 
C19 waves and for 
other future 
pandemics  
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
08.07.2020 Mounting evidence suggests 
coronavirus is airborne — but 
health advice has not caught up 
Nature | News feature Dyani Lewis 
08.07.2020 Women are most affected by 
pandemics — lessons from past 
outbreaks 
Nature | Comment Clare 
Wenham, Julia 
Smith et al 
08.07.2020 More on Clinical Characteristics of 
Pregnant Women with Covid-19 in 
Wuhan, China 
NEJM | Correspondance Lynne M. 
Mofenson,  
Andrea 
Ciaranello 
08.07.2020 Pandemics: why a new science is 
needed 
STEPS blog Ian Scoones 
June 2020 Cardiovascular care in sub-
Saharan Africa during the COVID-
19 crisis: lessons from the global 
experience 
Cardiovascular Journal of 
Africa | Editorial 
Kishal Lukhna, 
Blanche 
Cupido, Jens 
Hitzeroth, 
Ashley Chin, 
Mpiko Ntsekhe 
11 
August 
2020 
COVID-19, health rights of prison 
staff, and the bridge between 
prison and public health in Africa 
Public Health | Letter M C Van Hout 
03.07.2020 Covid-19: No large hidden 
outbreak in Africa but health 
worker shortage worsens 
BMJ | News Owen Dyer 
03.07.2020 Remdesivir: US purchase of world 
stocks sparks new “hunger 
games,” warn observers 
BMJ | News Jacqui Wise 
06.07.2020 Reset Sustainable Development 
Goals for a pandemic world  
Nature | Comment   
06.07.2020 Cambodia’s Response to COVID-
19 
JHBSPH | Podcast Dr. Kumanan 
Rasanathan, 
talks with Dr. 
Sara Bennett 
July 2020 COVID-19 testing in Africa: 
lessons learnt 
The Lancet Microbe | 
Comment 
Pascale 
Ondoa et al. 
July 2020 COVID-19: a multifaceted threat 
to refugee camps 
The Lancet Microbe | News Talha Burki 
July 2020 Development of potential COVID-
19 vaccines continues to 
accelerate 
The Lancet Microbe | News Tony Kirby 
06.07.2020 The Indirect Health Effects of 
COVID-19: long-term costs for 
health systems 
CGD | Blog Lydia Regan 
Y-Ling Chi 
06.07.2020 WHO: access to HIV medicines 
severely impacted by COVID-19 
as AIDS response stalls 
WHO | News 
 
06.07.2020 SARS-CoV-2 seroprevalence in 
COVID-19 hotspots 
The Lancet | Comment Isabella 
Eckerle 
12 
Benjamin 
Meyer 
03.07.2020 Six months of coronavirus: the 
mysteries scientists are still racing 
to solve 
Nature | News Ewen 
Callaway 
Heidi Ledford 
Smriti 
Mallapaty 
03.07.2020 Oxygen availability in sub-
Saharan African countries: a call 
for data to inform service delivery 
The Lancet Global 
Health  Correspondence 
Sowmya 
Mangipudi 
Andrew 
Leather 
Ahmed Seedat 
Justine Davies 
03.07.2020 Pulse oximetry in low-resource 
settings during the COVID-19 
pandemic 
The Lancet Global Health | 
Correspondence 
Nicola Starr et 
al. 
03.07.2020 Decisive leadership is a necessity 
in the COVID-19 response 
The Lancet | Comment Ahmed 
Mohammed 
Obaid Al Saidi 
et al. 
01.07.2020 How to predict – and prevent – the 
next pandemic 
The Economist | Weekly 
podcast (24 min) 
 
  
13 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
01.05.2020 COVID-19 
considerations for 
home and community 
care 
SSHAP 
 This review gives an overview of 
existing guidance and models for 
home and community-based care 
for C19, with an emphasis on 
LMICs 
 Gaps in the guidance are assessed 
and ways these may be addressed 
suggested. This includes 
highlighting innovative examples 
and drawing on knowledge of past 
outbreaks 
 Recommendations are aimed at 
governments, NGOs and relevant 
community-based organisations  
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
14 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-
19 
Vaccine 
Tracker 
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
  
15 
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
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COVID-19 
Digest 
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
17 
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Wednesday, 
July 15, 
2020 - 
9:30am to 
10:45am ET 
The Role of 
Parliamentarians in 
Strengthening COVID-
19 Response & 
Recovery 
Online event 1hr 15 Center for Global 
Development 
07.07.2020 
1300-1430 
BST 
Fifth Annual Health 
Financing Forum 
(AHFF): Health 
Financing Resilience 
and Sustainability 
Online event 1h 30 JLN, WB, USAID, 
GFF, GFF, CGD 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
18 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 3:00 
PM – 6:00 
PM BST 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the 
World Bank Group 
Online 
Lecture  
2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 
Zoom webinar   African Union & Africa 
CDC 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins 
School of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
19 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 2020 COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
FutureLearn 
LSHTM/UK PHRST 
20 
weekly 
study 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
 The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
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